Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB, has initiated a Phase IIb clinical study of its ChronVac-C DNA vaccine for hepatitis C virus, delivered by Inovio's proprietary electroporation DNA vaccine delivery technology, in combination with standard of care.

14 Mar 2011

External panel issues draft report saying WHO response to H1N1 lacked cohesion, clarity

An independent panel of experts commissioned by the WHO to probe its response to the H1N1 pandemic on Thursday released a draft report stating that while the organization performed well in many ways, it made "crucial mistakes" and "warned tens of millions could die if there is a severe flu outbreak in the future," the Associated Press reports.

14 Mar 2011

Swine flu pandemic declaration by WHO being investigated by experts

Experts who have been investigating the World Health Organization’s management of the response to the H1N1 pandemic have announced that they found no evidence that the drug industry influenced the agency’s decision making over how to handle the virus. In their draft report that panel of independent experts did acknowledge that the WHO failed to understand and respond to conflicts of interest among experts on its advisory Emergency Committee, which had previously acknowledged their pharmaceutical industry ties.

14 Mar 2011

New analytic method suggests tumors grow in punctuated, staccato-like bursts

A new method of analyzing cancerous tumors developed by scientists at Cold Spring Harbor Laboratory suggests that tumors may not evolve gradually, but rather in punctuated or staccato-like bursts.

14 Mar 2011

Flu pandemics may return & mutating strains: Studies

Scientists have warned that we have not seen the end of H1N1 swine flu that swept the globe in 2009/10. The strain of the virus could easily morph into a more transmissible form, while an older, mid-20th century virus could also come roaring back they say. Asian influenza, a H2N2 strain, first appeared in 1957 and killed one to four million people despite a major vaccination campaign. Studies have shown that most people today aged 50 or older retain some immunity to the virus, which continues to circulate in birds and swine. But the younger are more vulnerable they warn.

12 Mar 2011

NIH awards InDevR $3 million Phase II SBIR grant for influenza-related research

InDevR announced today that it has been awarded a Phase II Small Business Innovation Research grant from the National Institutes of Health in the amount of $3 million over the next 3 years.

11 Mar 2011

Genetic variant contributes to higher risk of lung cancer, increases tendency to smoke more

Norwegian researchers have discovered genes that increase not only one's risk of lung cancer, but perhaps one's urge to smoke as well. Now these researchers are working on developing a blood test for lung cancer.

11 Mar 2011

Walgreens sells Pharmacy Benefits Manager to Catalyst Health Solutions

Catalyst Health Solutions Inc said it will buy Walgreen Co's pharmacy benefits management unit for about $525 million in cash, a deal that might spur more consolidation before big generic drug launches that could boost the business.

11 Mar 2011

Researchers concerned about use of mercury-based compound in inactivated flu vaccines

As the United Nations, the European Commission, and the United States Food and Drug Administration evaluate the health and environmental risks associated with mercury, a known neurotoxin, carcinogen, mutagen, teratogen, and immune-system disruptor, new research continues to fuel concerns about Thimerosal, a mercury-based compound used as a preservative in inactivated flu vaccines.

11 Mar 2011

GSK announces new NovaMin-containing dental formulation for sensitive teeth

This year, for the first time, millions of Americans will be protecting their sensitive teeth with NovaMin in everyday dental products. Co-inventor Gary Hack, DDS, couldn't be happier.

11 Mar 2011

Positive preliminary results from Sinovac EV71 vaccine phase I trial in adults

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today the unblinding of the Phase I clinical trial results for the adult population for its proprietary inactivated vaccine against human enterovirus 71, which causes hand, foot, and mouth disease.

10 Mar 2011

Novartis new MS treatment receives Notice of Compliance in Canada

Novartis Pharmaceuticals Canada Inc. announced today that its new MS treatment, Gilenya, has received Notice of Compliance in Canada.

10 Mar 2011

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return

Despite dramatically improved survival rates for childhood acute lymphoblastic leukemia, relapse remains a leading cause of death from the disease. Work led by St. Jude Children's Research Hospital investigators identified mutations in a gene named CREBBP that may help the cancer resist steroid treatment and fuel ALL's return.

10 Mar 2011

House Foreign Affairs Committee hears testimony on security, human rights, health in Democratic Republic of Congo

At a House Committee on Foreign Affairs hearing on Tuesday, Ben Affleck, the actor, writer and director, and "other witnesses urged the Obama administration to immediately appoint a special envoy" for the Democratic Republic of Congo, which is due for a national election in November, CNN reports.

10 Mar 2011

Swine flu virus may evolve into a deadlier form

In the fall of 1917, a new strain of influenza swirled around the globe. At first, it resembled a typical flu epidemic: Most deaths occurred among the elderly, while younger people recovered quickly. However, in the summer of 1918, a deadlier version of the same virus began spreading, with disastrous consequence. In total, the pandemic killed at least 50 million people - about 3 percent of the world's population at the time.

10 Mar 2011

FDA accepts Tris' Extended Release Carbinoxamine Oral Suspension NDA for allergies in kids

Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced today that the US Food and Drug Administration (FDA) has accepted its Extended Release Carbinoxamine Oral Suspension NDA for the treatment of allergies in kids two years and older. If approved, Tris Pharma's Extended Release Suspension will provide an alternative to the currently available immediate release formulations.

10 Mar 2011

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

10 Mar 2011

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

9 Mar 2011

Also in global health news: Rights abuses in Myanmar; Indian malnutrition; Mali Global Fund grant; shift in USAID's programs in Afghanistan; Gates Foundation grant for vaccines

Human Rights Abuses Impacting Health Situation In Parts Of Myanmar, Study Says.

9 Mar 2011

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV

External panel issues draft report saying WHO response to H1N1 lacked cohesion, clarity

Swine flu pandemic declaration by WHO being investigated by experts

New analytic method suggests tumors grow in punctuated, staccato-like bursts

Flu pandemics may return & mutating strains: Studies

NIH awards InDevR $3 million Phase II SBIR grant for influenza-related research

Genetic variant contributes to higher risk of lung cancer, increases tendency to smoke more

Walgreens sells Pharmacy Benefits Manager to Catalyst Health Solutions

Researchers concerned about use of mercury-based compound in inactivated flu vaccines

GSK announces new NovaMin-containing dental formulation for sensitive teeth

Positive preliminary results from Sinovac EV71 vaccine phase I trial in adults

Novartis new MS treatment receives Notice of Compliance in Canada

Idera reports $6.0 million net loss for fourth quarter 2010

Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return

House Foreign Affairs Committee hears testimony on security, human rights, health in Democratic Republic of Congo

Swine flu virus may evolve into a deadlier form

FDA accepts Tris' Extended Release Carbinoxamine Oral Suspension NDA for allergies in kids

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Also in global health news: Rights abuses in Myanmar; Indian malnutrition; Mali Global Fund grant; shift in USAID's programs in Afghanistan; Gates Foundation grant for vaccines

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in